Author

Douglas R Davies

UCB Pharma (United States)ORCID 0000-0002-3729-3463Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:protein structure· 1

Frequent Co-Authors

Bart L. StakeriD· 1 shared Bram Osterhout· 1 shared Brandy M. CalhouniD· 1 shared Christopher A. RiceiD· 1 shared Craig L. SmithiD· 1 shared David M. DranowiD· 1 shared Dennis E. KyleiD· 1 shared Donald D. LorimeriD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Bart L. StakerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Naegleria fowleri: protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba

Kayleigh F. Barrett, Logan M. Tillery, Jenna Goldstein, Jared W. Lassner, Bram Osterhout, Nathan L. Tran, Lily Xu, Ryan M. Young, Justin K. Craig, Ian K. H. Chun, David M. Dranow, Jan A. Abendroth, Silvia L. Delker, Douglas R Davies, Stephen J. Mayclin, , Wesley C. Van Voorhis A

The paper reports the structural determination of 19 N. fowleri proteins, identifying potential drug targets with structural differences from human homologs.

PLoS ONE · Mar 24, 2021Peer-reviewedMolecular Biology